Immuneering Corp. (IMRX)
3.495
+0.04
(+1.01%)
USD |
NASDAQ |
Nov 18, 16:00
3.495
0.00 (0.00%)
After-Hours: 19:19
Immuneering Price : 3.495 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.58 | 3.63 | 3.31 | 3.46 | 1.248M |
| Nov 16, 2026 | 3.70 | 3.78 | 3.475 | 3.52 | 1.020M |
| Nov 13, 2026 | 3.71 | 3.746 | 3.545 | 3.71 | 849190.0 |
| Nov 12, 2026 | 3.86 | 3.885 | 3.65 | 3.67 | 480000.0 |
| Nov 11, 2026 | 3.89 | 3.95 | 3.79 | 3.79 | 455930.0 |
| Nov 10, 2026 | 3.66 | 3.895 | 3.64 | 3.85 | 769414.0 |
| Nov 09, 2026 | 3.69 | 3.725 | 3.53 | 3.65 | 849135.0 |
| Nov 06, 2026 | 3.41 | 3.70 | 3.368 | 3.68 | 681548.0 |
| Nov 05, 2026 | 3.74 | 3.74 | 3.35 | 3.37 | 764400.0 |
| Nov 04, 2026 | 3.74 | 3.87 | 3.70 | 3.76 | 730604.0 |
| Nov 03, 2026 | 3.52 | 3.76 | 3.52 | 3.68 | 877868.0 |
| Nov 02, 2026 | 3.76 | 3.94 | 3.445 | 3.49 | 799889.0 |
| Oct 30, 2026 | 4.01 | 4.07 | 3.72 | 3.745 | 1.139M |
| Oct 29, 2026 | 3.99 | 4.10 | 3.87 | 4.02 | 777033.0 |
| Oct 28, 2026 | 3.80 | 4.155 | 3.79 | 3.99 | 1.443M |
| Oct 27, 2026 | 3.72 | 3.888 | 3.70 | 3.83 | 700080.0 |
| Oct 26, 2026 | 3.73 | 3.78 | 3.65 | 3.71 | 579803.0 |
| Oct 23, 2026 | 3.78 | 3.78 | 3.585 | 3.73 | 726539.0 |
| Oct 22, 2026 | 3.72 | 3.835 | 3.70 | 3.81 | 527135.0 |
| Oct 21, 2026 | 3.73 | 3.80 | 3.680 | 3.74 | 481882.0 |
| Oct 20, 2026 | 3.70 | 3.841 | 3.67 | 3.73 | 926845.0 |
| Oct 19, 2026 | 3.61 | 3.67 | 3.560 | 3.66 | 427112.0 |
| Oct 16, 2026 | 3.65 | 3.68 | 3.575 | 3.59 | 747890.0 |
| Oct 15, 2026 | 3.42 | 3.71 | 3.38 | 3.64 | 934285.0 |
| Oct 14, 2026 | 3.51 | 3.598 | 3.41 | 3.42 | 805722.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
| Savara, Inc. | 4.735 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
Price Related Metrics
| Price to Book Value | 1.342 |
| Earnings Yield | -29.42% |
| Market Cap | 226.35M |